WallStreetZenWallStreetZen

NASDAQ: GRCL
Gracell Biotechnologies Inc Stock

Open Broker Account
$3.22+0.62 (+23.85%)
Updated Sep 30, 2022
GRCL Price
$3.22
Fair Value Price
$25.90
Market Cap
$217.91M
52 Week Low
$1.68
52 Week High
$15.00
P/E
-2.63x
P/B
0.91x
P/S
6,813.34x
PEG
N/A
Dividend Yield
N/A
Revenue
$54.06k
Earnings
-$83.99M
Gross Margin
100%
Operating Margin
-152,256.94%
Profit Margin
-154,302.5%
Debt to Equity
0.5
Operating Cash Flow
N/A
Beta
0.97
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

GRCL Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GRCL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GRCL ($3.22) is undervalued by 87.57% relative to our estimate of its Fair Value price of $25.90 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
GRCL ($3.22) is significantly undervalued by 87.57% relative to our estimate of its Fair Value price of $25.90 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
GRCL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more GRCL due diligence checks available for Premium users.

Be the first to know about important GRCL news, forecast changes, insider trades & much more!

GRCL News

Valuation

GRCL fair value

Fair Value of GRCL stock based on Discounted Cash Flow (DCF)
Price
$3.22
Fair Value
$25.90
Undervalued by
87.57%
GRCL ($3.22) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
GRCL ($3.22) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
GRCL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

GRCL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.63x
Industry
14.28x
Market
27.64x

GRCL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.91x
Industry
4.39x
GRCL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GRCL's financial health

Profit margin

Revenue
$0.0
Net Income
-$21.8M
Profit Margin
0%
GRCL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$40.3M
Liabilities
$120.6M
Debt to equity
0.5
GRCL's short-term liabilities ($102.72M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GRCL's short-term assets ($31.75M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GRCL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A

GRCL vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
GRCL$217.91M+23.85%-2.63x0.91x
MOLN$217.44M+7.73%N/A0.79x
ALPN$218.88M+0.42%-3.73x2.20x
LIAN$216.71M-0.50%1.31x0.74x
VECT$219.81M+26.05%-1.86x1.89x

Gracell Biotechnologies Stock FAQ

What is Gracell Biotechnologies's quote symbol?

NASDAQ: GRCL) Gracell Biotechnologies trades on the NASDAQ under the ticker symbol GRCL. Gracell Biotechnologies stock quotes can also be displayed as NASDAQ: GRCL.

If you're new to stock investing, here's how to buy Gracell Biotechnologies stock.

What is the 52 week high and low for Gracell Biotechnologies (NASDAQ: GRCL)?

(NASDAQ: GRCL) Gracell Biotechnologies's 52-week high was $15.00, and its 52-week low was $1.68. It is currently -78.53% from its 52-week high and 91.67% from its 52-week low.

How much is Gracell Biotechnologies stock worth today?

(NASDAQ: GRCL) Gracell Biotechnologies currently has 338,370,624 outstanding shares. With Gracell Biotechnologies stock trading at $3.22 per share, the total value of Gracell Biotechnologies stock (market capitalization) is $217.91M.

Gracell Biotechnologies stock was originally listed at a price of $25.06 in Jan 8, 2021. If you had invested in Gracell Biotechnologies stock at $25.06, your return over the last 1 years would have been -87.15%, for an annualized return of -87.15% (not including any dividends or dividend reinvestments).

How much is Gracell Biotechnologies's stock price per share?

(NASDAQ: GRCL) Gracell Biotechnologies stock price per share is $3.22 today (as of Sep 30, 2022).

What is Gracell Biotechnologies's Market Cap?

(NASDAQ: GRCL) Gracell Biotechnologies's market cap is $217.91M, as of Oct 2, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Gracell Biotechnologies's market cap is calculated by multiplying GRCL's current stock price of $3.22 by GRCL's total outstanding shares of 338,370,624.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.